IGFBP1 and Insulin resistance: Unless the explaination is that the increased waist is a surrogate marker of liver steatosis, hepatic insulin resistance, and low IGFBP-1 levels23 which is corrected by RYGB reducing liver steatosis thus improving insulin sensitivity and glucose tolerance.